Next Article in Journal
Acute Pulmonary Embolism in Patients with and without COVID-19
Next Article in Special Issue
The Effect of Probiotics on Quality of Life, Depression and Anxiety in Patients with Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
Previous Article in Journal
Genital Tract GAS Infection ISIDOG Guidelines
 
Search for Articles:
Title / Keyword
Author / Affiliation
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
Journals
JCM
Volume 10
Issue 9
10.3390/jcm10092044
jcm-logo
Submit to this Journal Review for this Journal Edit a Special Issue
► Article Menu

Article Menu

share announcement question_answer thumb_up
...
textsms
...
Article

The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database

by
Gyu Lee Kim
1,2,
Yu Hyeon Yi
1,2,*,
Hye Rim Hwang
1,2,
Jinmi Kim
3,
Youngmin Park
4,
Yun Jin Kim
1,2,
Jeong Gyu Lee
1,2,
Young Jin Tak
1,2,
Seung Hun Lee
1,2,
Sang Yeoup Lee
2,5,
Youn Hye Cho
2,5,
Eun Ju Park
2,5 and
Youngin Lee
2,5
1
Department of Family Medicine, Medical Research Institute and Busan Tobacco Control Center, Pusan National University Hospital, Busan 49241, Korea
2
Pusan National University School of Medicine, Yangsan 50612, Korea
3
Clinical Trial Center, Department of Biostatistics, Biomedical Research Institute, Pusan National University Hospital, Busan 49241, Korea
4
Department of Family Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Korea
5
Family Medicine Clinic, Obesity, Metabolism and Nutrition Center Pusan National University Yangsan Hospital, Yangsan 50612, Korea
*
Author to whom correspondence should be addressed.
Academic Editor: Gabrio Bassotti
J. Clin. Med. 2021, 10(9), 2044; https://doi.org/10.3390/jcm10092044
Received: 26 February 2021 / Revised: 1 May 2021 / Accepted: 5 May 2021 / Published: 10 May 2021
(This article belongs to the Collection Latest Research in Irritable Bowel Syndrome)
View Full-Text Download PDF
Browse Figures

Abstract

Patients with irritable bowel syndrome (IBS) are at increased risk of osteoporosis and osteoporotic fracture. This study investigated whether IBS medication attenuated the rate of osteoporosis and osteoporotic fracture risk. We conducted a retrospective large-scale multicenter study across eight hospital databases encoded in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM). The primary outcome was the incidence of osteoporosis, whereas secondary outcomes were osteoporotic fractures. After 1:4 matching, 24,723 IBS patients, 78,318 non-IBS patients, 427,640 non-IBS patients with IBS medication, and 827,954 non-IBS patients without IBS medication were selected. The risk of osteoporosis was significantly increased in the IBS group compared to the non-IBS group (hazard ratio (HR) 1.33; confidence interval (CI) 1.17~1.51). Even in patients who were not diagnosed with IBS, the risk of osteoporosis was significantly increased in those with IBS medication compared to those without (HR 1.77, CI 1.62~1.93). The risk of osteoporotic fracture was significantly increased in the IBS medication group (HR 1.69, CI 1.55~1.84). Patients exposed to IBS treatment even without IBS diagnosis were at increased risk of osteoporosis and osteoporotic fracture. Early diagnosis and treatment of osteoporosis should be considered in patients who have received medication for IBS symptoms. View Full-Text
Keywords: irritable bowel syndrome; osteoporosis; treatment for IBS irritable bowel syndrome; osteoporosis; treatment for IBS
►▼ Show Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Supplementary Material

SciFeed

Share and Cite

MDPI and ACS Style

Kim, G.L.; Yi, Y.H.; Hwang, H.R.; Kim, J.; Park, Y.; Kim, Y.J.; Lee, J.G.; Tak, Y.J.; Lee, S.H.; Lee, S.Y.; Cho, Y.H.; Park, E.J.; Lee, Y. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database. J. Clin. Med. 2021, 10, 2044. https://doi.org/10.3390/jcm10092044

AMA Style

Kim GL, Yi YH, Hwang HR, Kim J, Park Y, Kim YJ, Lee JG, Tak YJ, Lee SH, Lee SY, Cho YH, Park EJ, Lee Y. The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database. Journal of Clinical Medicine. 2021; 10(9):2044. https://doi.org/10.3390/jcm10092044

Chicago/Turabian Style

Kim, Gyu L., Yu H. Yi, Hye R. Hwang, Jinmi Kim, Youngmin Park, Yun J. Kim, Jeong G. Lee, Young J. Tak, Seung H. Lee, Sang Y. Lee, Youn H. Cho, Eun J. Park, and Youngin Lee. 2021. "The Risk of Osteoporosis and Osteoporotic Fracture Following the Use of Irritable Bowel Syndrome Medical Treatment: An Analysis Using the OMOP CDM Database" Journal of Clinical Medicine 10, no. 9: 2044. https://doi.org/10.3390/jcm10092044

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Metrics

Article Access Map by Country/Region

1
Back to TopTop